Remove Biotech Remove Blockchain Remove Development
article thumbnail

TechCrunch+ roundup: Psychedelic biotech, Gogoro’s SPAC, H-1Bs for Ukrainians

TechCrunch

6 questions investors should ask when evaluating psychedelic biotech companies. With plans to raise a $25 million fund and more than $15 million already invested, PsyMed Ventures focuses on early-stage startups developing psychedelic therapeutics. 6 questions investors should ask when evaluating psychedelic biotech companies. .

Biotech 222
article thumbnail

Tackling Multidomain Integration in Software Development

Dzone - DevOps

Multidomain integration is becoming a cornerstone of modern software development, bridging technologies like blockchain, biotech, and consumer applications. These cross-domain projects are no longer optional they are the future of innovation. However, combining such diverse systems presents unique challenges.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Crypto-focused Dragonfly Capital launches $650M third fund

TechCrunch

Dragonfly plans to focus its investments across all stages of blockchain and crypto-native companies, protocols, and tokens. “We It’s like investing in crypto without understanding technology is like investing in biotech without understanding biology. You’d be missing the core mechanics of what you’re investing in.”.

article thumbnail

Sectors where New Zealand startups are poised to win

TechCrunch

Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. Blockchain NZ Chair Bryan Ventura. Now, certain industries are emerging as potential areas where New Zealand can win in the tech space.

article thumbnail

The Week’s Biggest Funding Rounds: NinjaOne Cuts To The Top 

Crunchbase News

Not surprisingly, those two rounds came from the cybersecurity and biotech industries. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in this young year. Raise , $63M, loyalty: Miami-based Raise, a gift cards and loyalty company, raised $63 millionled by Haun Ventures.

Biotech 73
article thumbnail

The Week’s 10 Biggest Funding Rounds: Cyera And Monad Labs Raise Massive Rounds In Big Week

Crunchbase News

Monad Labs , $225M, blockchain: New York-based Monad Labs locked up the biggest Web3 funding round of the year thus far, collecting a $225 million funding round led by Paradigm. Monad is a layer-1 blockchain that is compatible with the Ethereum Virtual Machine but can process transactions using the same set of rules faster.

Biotech 126
article thumbnail

The Week’s 10 Biggest Funding Rounds: Cybersecurity Leads With Kiteworks’ Nearly Half-Billion-Dollar Deal

Crunchbase News

Halda Therapeutics , $126M, biotech: The big biotech round of the week came from New Haven, Connecticut-based Halda Therapeutics, a biotech startup developing therapies for prostate cancer and breast cancer, which raised a $126 million Series B extension from investors including Deep Track Capital and RA Capital Management.

Biotech 126